ArticleAdvances in therapy2024

Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT.

Dédée F Murrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.